Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Novel MRI for an Earlier Diagnosis of Motor Neurone Disease (MRF MND)

11 november 2026 uppdaterad av: The Leeds Teaching Hospitals NHS Trust

The goal of the study is Can MR Fingerprinting identify quantitative differences in brains of patients with MND and age-matched healthy controls?

Studieöversikt

Status

Rekrytering

Intervention / Behandling

Detaljerad beskrivning

The Investigators will recruit consecutive patients with MND, identified via the Leeds MND clinic.

Patients will be provided with a patient information sheet (PIS) when they attend the clinic and will have the opportunity to discuss the study with a clinician and ask questions.

If they are willing and able to provide informed consent at this time, consent will be taken, and the participant will be reassured they may withdraw at any time. If the patient wishes time to consider the study, with their permission, they will be contacted via telephone after 24 hours and asked whether or not they wish to be included, again reassured they may withdraw at any time.

An email inviting individuals aged 18 or over to undergo MR imaging of the brain will be distributed throughout Leeds Teaching Hospitals Trust. Those interested will be asked to send their contact details via e-mail reply to the Department of Neuroradiology.

Potential participants will be contacted by a member of the research team and will be taken through a pre-prepared questionnaire detailing present and past medical history. Individuals that answer negatively for the presence of chronic or current illness, particularly regarding neurological disease or psychiatric conditions and that are free from medication and that satisfy MR safety regulations (i.e. no cardiac pacemakers or metallic implants) will be provided with an MRI appointment. All participants will be sent (via email and at least 24 hours prior to the MRI appointment) a PIS. Informed consent will be obtained on arrival for their MRI appointment by a member of the research team.

A consultant neuroradiologist will review all imaging for both cohorts. Any incidental pathology discovered on the MRI requiring medical review will be recorded as a 'Foreign Films for Opinion' on the the Leeds Teaching Hospitals Trust radiology information system and will be alerted to the volunteers' GP, reflecting pre-existing practice within Leeds Teaching Hospitals Trust for research imaging studies.

Studietyp

Observationell

Inskrivning (Beräknad)

20

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studieorter

    • West Yorkshire
      • Leeds, West Yorkshire, Storbritannien, LS9 7TF
        • Rekrytering
        • Leeds Teaching Hospitals NHS Trust

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Allt

Testmetod

Icke-sannolikhetsprov

Studera befolkning

The target population will be patients with MND attending the MND clinic, Leeds Teaching Hospitals Trust and healthy volunteers of workers or relatives of workers within Leeds Teaching Hospitals Trust.

Although MND (ALS) can strike at any age, symptoms most commonly develop between the ages of 55 and 75. Men are slightly more likely to develop ALS than women. However, at older ages, men and women are equally likely to be diagnosed with ALS. Whites and non-Hispanics are most likely to develop the disease, but ALS affects people of all races and ethnic backgrounds.

Beskrivning

Inclusion criteria all participants:

  • ≥18yrs
  • Able and willing to provide consent
  • Able to communicate with staff and safely comply with the study procedures

Additional inclusion criteria for MND participants:

  • ALS patients with definite or probable motor neuron disease based on the Awaji criteria

Additional inclusion criteria for healthy volunteers:

  • Free from chronic or current illness particularly:
  • Neurological disorders including migraines
  • Psychiatric disorders
  • Prior head injury resulting in brain damage
  • Prior neurosurgical or neurovascular intervention
  • Free from taking medication
  • Non-drug and non-alcohol abuse
  • Non-smoker

Exclusion criteria all participants:

  • Contraindication to MRI, including:

    • non-MRI compatible medical devices and implants
    • in patients with previous penetrating trauma to the eye, or patients at high risk of previous metal foreign body injury to the eye (e.g. welding), skull x-ray will be performed; these patients may be included in the absence of residual metal fragments on x-ray
    • Inability to lie flat in the MRI scanner
    • ALS patients in an advanced disease stage (ALSFRS-R < 25) with respiratory insufficiency (forced vital capacity (FVC) < 60%), on non-invasive ventilation or receiving percutaneous gastrostomy feeding.
  • Pregnant

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Observationsmodeller: CASE_CONTROL
  • Tidsperspektiv: PROSPECTIVE

Kohorter och interventioner

Grupp / Kohort
Intervention / Behandling
MND Patients

MND

MRI of the brain including MRF

Healthy Volunteers

Healthy volunteers of workers or relatives of workers within Leeds Teaching Hospitals Trust

MRI of the brain including MRF

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Quantitative values of brain cortical regions on MRF
Tidsram: Scan time of less than 60 minutes

Both cohorts will undergo the same MRI protocol comprising routine clinical structural imaging of the brain and MRF; with a scan time of less than 60 minutes.

All images from both cohorts will be reviewed by a consultant neuroradiologist. Should there be any unexpected findings, the volunteers' GP will be informed in writing.

After the scan, the volunteers from both cohorts will be free to leave, at which point their direct participation in the study will concluded.

Scan time of less than 60 minutes

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

20 oktober 2026

Primärt slutförande (Beräknad)

31 maj 2027

Avslutad studie (Beräknad)

31 maj 2027

Studieregistreringsdatum

Först inskickad

23 oktober 2026

Först inskickad som uppfyllde QC-kriterierna

11 november 2026

Första postat (Faktisk)

17 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

17 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

11 november 2026

Senast verifierad

1 oktober 2026

Mer information

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera